The Texas Heart Institute Provides BiVACOR® Total Artificial Heart Patient Update
Successful first-in-human bridge to heart transplant with revolutionary valveless artificial heart Houston, Texas, July 26, 2024 – The Texas Heart...
Research & Innovations
The Texas Heart Institute Implants BiVACOR® Total Artificial Heart
First-in-human novel valveless artificial heart implanted in a patient with end-stage heart failure as a bridge to heart transplant ...
A Discovery by The Texas Heart Institute & 7 Hills Pharma Continues Development under a $4.7 Million CPRIT Grant to Address Cancer Treatment Disparities
Peter Vanderslice, PhD, Senior Investigator and Director, MCRL, Molecular Cardiology Research, was highlighted in a recent announcement from 7 Hills Pharma,...
Dr. Matthew Segar Recognized With DEI Abstract Award From Heart Rhythm Society
Novel Machine Learning Model Improves Prediction of Atrial Fibrillation Risk The Heart Rhythm Society recently recognized Matthew Segar, MD,...
Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia
Dr. Christie Mitchell Ballantyne, editorial board member for The Texas Heart Institute Journal, and professor of medicine and chief of...
Fellow Dr. Matthew Segar Contributes to Online Resource for Cardiologists
Matthew Segar, MD, MS, a third-year fellow in The Texas Heart Institute Cardiovascular Disease Fellowship at Baylor St. Luke’s Medical...
Rice University Heartbeat HERoes Take Top Engineering Prize for Collaboration With The Texas Heart Institute
The Heartbeat HERoes recently won the 2024 Woods-Lezar Innovation Award at Rice University’s annual Huff Oshman Engineering Design Kitchen’s (OEDK)...
Novel Injectable Hydrogel Technology Featured in Drug Discovery News
A recent article in Drug Discovery News highlights a new injectable hydrogel technology and its potential to provide painless defibrillation...
Creative Strategies Used to Save COVID Patient Who Needed 149 Days of Extracorporeal Membrane Oxygenation
Infection with COVID-19 can take many forms. It can be mild enough to be mistaken for the common cold, or...
The Texas Heart Institute Leads New NIH-Funded Project to Significantly Improve LVADs
HOUSTON (March 20, 2024) — The Texas Heart Institute® and its collaborators at the Georgia Institute of Technology (Georgia Tech),...
The Texas Heart Institute Collaborates on Multi-Institutional DOD Grant To Develop Novel Left Ventricular Assist Device
Georgia Tech-led effort to improve support device options for end-stage heart failure HOUSTON (Mar 7, 2024) — The Texas...
